Actualités Feb 29, 2024 Les Grands Titres de Suisse occidentale (Février 2024) D’importantes avancées en matière de semi-conducteurs et de percées dans la recherche médicale à des avancées stratégiques dans les secteurs de l...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Actualités Sep 29, 2023 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
News Feb 29, 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News Jan 29, 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News Jan 10, 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News Nov 01, 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
News Oct 23, 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
Aktuell Oct 18, 2022 KetoSwiss erhöht Kapital um 4 Millionen Dollar KetoSwiss hat von Investoren 4 Millionen Dollar erhalten. Das Basler Start-up entwickelt Produkte zur Linderung neurologischer Erkankungen wie Mi...
News Oct 25, 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News Sep 29, 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
Aktuell Dec 07, 2022 Kanada lässt Novocures Therapie für Hirntumor zu Novocure hat in Kanada die Zulassung seiner Therapie zur Behandlung des besonders aggressiven Glioblastoms erhalten. Für diesen häufigsten primär...
News Aug 14, 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Actualités Mar 08, 2021 Debiopharm signe un contrat de plus de EUR 900 millions avec Merck Debiopharm a accordé une licence mondiale exclusive au géant pharmaceutique Merck pour le développement et la commercialisation de son médicament...
Aktuell Nov 10, 2021 Kollagenmembran von Geistlich Pharma erhält Zulassung in den USA Geistlich Nexo-Gide hat die Zulassung der amerikanischen Aufsichtsbehörde erhalten. Die von Geistlich Pharma entwickelte Kollagenmembran unterstü...
News Jun 16, 2023 Saiba Animal Health issues license to Boehringer Ingelheim German pharmaceutical company Boehringer Ingelheim has secured an exclusive license for a Saiba Animal Health product candidate. This is the seco...
Aktuell Jan 19, 2021 Tessiner Ebola-Medikament ist in Amerika zugelassen Die amerikanische Behörde für Arzneimittelsicherheit (FDA) hat ein Ebola-Medikament zugelassen, das auf der Arbeit zweier Labors aus der Greater ...
News Mar 08, 2023 Bachem receives order totaling more than 500 million Swiss francs Bachem has signed a long-term cooperation agreement for the development and production of peptides. It includes a binding order volume of more th...